HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ZEB2
zinc finger E-box binding homeobox 2
Chromosome 2 Β· 2q22.3
NCBI Gene: 9839Ensembl: ENSG00000169554.24HGNC: HGNC:14881UniProt: O60315
351PubMed Papers
21Diseases
0Drugs
393Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedTranscription Factor
RESEARCH IMPACT
Highly StudiedTrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA-binding transcription repressor activity, RNA polymerase II-specificprotein bindingnegative regulation of transcription by RNA polymerase IIMowat-Wilson syndromegenetic disordercoronary artery diseasediabetes mellitus
✦AI Summary

ZEB2 (zinc finger E-box binding homeobox 2) is a transcriptional repressor that binds to DNA sequences and regulates multiple developmental and immune processes. The protein functions as a master regulator controlling cell fate transitions across different tissue types. In immune cells, ZEB2 drives the formation of age-associated B cells (ABCs) by binding to enhancer regions and repressing germinal center differentiation programs while promoting autoimmune-associated cell states 1. ZEB2 also controls the formation of CD4+ age-associated T helper cells that exhibit cytotoxic and B cell helper functions 2, and regulates tumor-associated macrophage programs by suppressing interferon responses and antigen presentation 3. In vascular biology, ZEB2 mediates smooth muscle cell phenotypic transitions through chr2 remodeling, affecting Notch and TGF-Ξ² signaling pathways and influencing atherosclerotic plaque characteristics 4. During brain development, ZEB2 promotes neuroepithelial cell shape transitions critical for human forebrain expansion 5. Clinically, ZEB2 haploinsufficiency causes Mowat-Wilson syndrome, a multisystem disorder characterized by intellectual disability, distinctive facial features, and various congenital malformations including Hirschsprung disease 6. The gene's diverse functions highlight its importance as a master transcriptional switch controlling cellular differentiation programs across multiple organ systems.

Sources cited
1
ZEB2 drives age-associated B cell formation by binding enhancers and repressing germinal center differentiation
PMID: 38271512
2
ZEB2 regulates CD4+ age-associated T helper cells with cytotoxic and B cell helper functions
PMID: 38330141
3
ZEB2 controls tumor-associated macrophage programs by suppressing interferon responses
PMID: 40215981
4
ZEB2 mediates smooth muscle cell transitions through chromatin remodeling affecting Notch/TGF-Ξ² signaling
PMID: 34990206
5
ZEB2 promotes neuroepithelial cell shape transitions critical for human brain expansion
PMID: 33765444
6
ZEB2 haploinsufficiency causes Mowat-Wilson syndrome with intellectual disability and congenital malformations
PMID: 17958891
Disease Associationsβ“˜21
Mowat-Wilson syndromeOpen Targets
0.83Strong
genetic disorderOpen Targets
0.55Moderate
coronary artery diseaseOpen Targets
0.51Moderate
diabetes mellitusOpen Targets
0.47Moderate
heart failureOpen Targets
0.46Moderate
Neurodevelopmental disorderOpen Targets
0.46Moderate
type 2 diabetes mellitusOpen Targets
0.44Moderate
hypertensionOpen Targets
0.44Moderate
Intellectual disabilityOpen Targets
0.44Moderate
migraine disorderOpen Targets
0.42Moderate
aortic valve diseaseOpen Targets
0.41Moderate
heart diseaseOpen Targets
0.41Moderate
type 2 diabetes nephropathyOpen Targets
0.41Moderate
Hirschsprung diseaseOpen Targets
0.40Moderate
obesityOpen Targets
0.39Weak
atrial fibrillationOpen Targets
0.37Weak
neurodegenerative diseaseOpen Targets
0.37Weak
Marden-Walker syndromeOpen Targets
0.37Weak
Muckle-Wells syndromeOpen Targets
0.37Weak
neuroinflammatory disorderOpen Targets
0.37Weak
Mowat-Wilson syndromeUniProt
Pathogenic Variants393
NM_014795.4(ZEB2):c.3046C>T (p.Arg1016Ter)Pathogenic
not provided|Intellectual disability|Mowat-Wilson syndrome|Inborn genetic diseases
β˜…β˜…β˜†β˜†2026β†’ Residue 1016
NM_014795.4(ZEB2):c.625C>T (p.Gln209Ter)Pathogenic
Abnormality of the nervous system|Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 209
NM_014795.4(ZEB2):c.2886+1G>APathogenic
Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2025
NM_014795.4(ZEB2):c.2761C>T (p.Arg921Ter)Pathogenic
Mowat-Wilson syndrome|not provided|Intellectual disability|Inborn genetic diseases|See cases
β˜…β˜…β˜†β˜†2025β†’ Residue 921
NM_014795.4(ZEB2):c.2083C>T (p.Arg695Ter)Pathogenic
Mowat-Wilson syndrome|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 695
NM_014795.4(ZEB2):c.2072G>A (p.Trp691Ter)Pathogenic
Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 691
NM_014795.4(ZEB2):c.3082C>T (p.Gln1028Ter)Pathogenic
See cases|Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 1028
NM_014795.4(ZEB2):c.2718del (p.Ala907fs)Pathogenic
not provided|Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 907
NM_014795.4(ZEB2):c.1426dup (p.Met476fs)Pathogenic
Mowat-Wilson syndrome|not provided|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 476
NM_014795.4(ZEB2):c.3171_3172del (p.Cys1057_Asp1058delinsTer)Pathogenic
Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 1057
NM_014795.4(ZEB2):c.2717del (p.Pro906fs)Pathogenic
Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 906
NM_014795.4(ZEB2):c.1541del (p.Pro514fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 514
NM_014795.4(ZEB2):c.3164A>G (p.Tyr1055Cys)Likely pathogenic
Mowat-Wilson syndrome|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 1055
NM_014795.4(ZEB2):c.73+2dupPathogenic
not provided|Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2025
NM_014795.4(ZEB2):c.1910C>A (p.Ser637Ter)Pathogenic
Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2024β†’ Residue 637
NM_014795.4(ZEB2):c.851G>A (p.Cys284Tyr)Likely pathogenic
Mowat-Wilson syndrome|Inborn genetic diseases
β˜…β˜…β˜†β˜†2024β†’ Residue 284
NM_014795.4(ZEB2):c.1489C>T (p.Gln497Ter)Pathogenic
Mowat-Wilson syndrome|Inborn genetic diseases
β˜…β˜…β˜†β˜†2024β†’ Residue 497
NM_014795.4(ZEB2):c.2095C>T (p.Gln699Ter)Pathogenic
Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2024β†’ Residue 699
NM_014795.4(ZEB2):c.2177_2180del (p.Ser726fs)Pathogenic
Mowat-Wilson syndrome
β˜…β˜…β˜†β˜†2024β†’ Residue 726
NM_014795.4(ZEB2):c.3218A>G (p.His1073Arg)Pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 1073
View on ClinVar β†—
Related Genes
CDH1Protein interaction95%CTBP1Protein interaction95%CTBP2Protein interaction95%TWIST2Protein interaction94%SOX2Protein interaction88%HDAC2Protein interaction84%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
57%
Heart
38%
Ovary
28%
Lung
26%
Liver
5%
Gene Interaction Network
Click a node to explore
ZEB2CDH1CTBP1CTBP2TWIST2SOX2HDAC2
PROTEIN STRUCTURE
Preparing viewer…
PDB2DA7 Β· NMR
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.11Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.06 [0.03–0.11]
RankingsWhere ZEB2 stands among ~20K protein-coding genes
  • #897of 20,598
    Most Researched351 Β· top 5%
  • #142of 5,498
    Most Pathogenic Variants393 Β· top 5%
  • #94of 17,882
    Most Constrained (LOEUF)0.11 Β· top 1%
Genes detectedZEB2
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
The transcription factor ZEB2 drives the formation of age-associated B cells.
PMID: 38271512
Science Β· 2024
1.00
2
ZEB2 is a master switch controlling the tumor-associated macrophage program.
PMID: 40215981
Cancer Cell Β· 2025
0.90
3
Age-associated CD4
PMID: 38330141
Sci Immunol Β· 2024
0.80
4
An early cell shape transition drives evolutionary expansion of the human forebrain.
PMID: 33765444
Cell Β· 2021
0.70
5
Neurological Phenotype of Mowat-Wilson Syndrome.
PMID: 34199024
Genes (Basel) Β· 2021
0.64